Drugs for treating fibromyalgia: Review and analysis of the literature;Des médicaments pour traiter la fibromyalgie? Revue et analyse de la littérature

Revue du Rhumatisme (Edition Francaise)

Volumn 70, Issue 4, 2003, Pages 340-345

  Perrot, Serge ^a  

^a Institut Cochin   (France)

Author keywords

Fibromyalgia; Pain; Pharmacological treatment

Indexed keywords

5 HYDROXYTRYPTOPHAN; ACETYLSALICYLIC ACID; ALPRAZOLAM; AMITRIPTYLINE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CALCITONIN; CARISOPRODOL; CLONAZEPAM; CORTICOSTEROID; CYCLOBENZAPRINE; FLUOXETINE; IBUPROFEN; KETAMINE; LIDOCAINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; RITANSERIN; S ADENOSYLMETHIONINE; TENOXICAM; ZOLPIDEM; ZOPICLONE;

CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG EFFICACY; FIBROMYALGIA; HEALTH SURVEY; HORMONAL REGULATION; HUMAN; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL RESEARCH; PATHOPHYSIOLOGY; POPULATION RESEARCH; PSYCHIATRY; PSYCHOANALYSIS; QUESTIONNAIRE; REVIEW; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT OUTCOME;

EID: 12244274638     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(03)00106-6     Document Type: Review

References (57)

1. Cathebras P. La fibromyalgie survivra-t-elle au siècle? Rev Med Interne 2000;21:577-9.
2. Hench PK. Evaluation and differential diagnosis of fibromyalgia: approach to diagnosis and management. Rheum Dis Clin North Am 1989;15:19-29.
3. Benoist M, Boulu P, Fuster TM, Kahn MF, Cambier J. Le syndrome polyalgique idiopathique diffus. Nouv Presse Méd 1986;15:1680-2.
4. Wolfe F, Ross K, Anderson J. The prevalence and characterisitics of fibromyalgia in the general population. Arthritis Rheum 1995;38: 19-28.
5. Clark S, Tindall E, Bennett RM. A double-blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985;12:980-3.
6. Caruso I, Saerzi Puttini P, Cazzola M, Azzolini;. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18:201-9.
7. Quimby LG, Gratwick GM, Whitney CD, Blocka SR. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 1989(Suppl. 19):140-3.
8. Bibolotti E, Borghi C, Pasculli E, Regoli F, Tavoni A, Baroni L, et al. The management of fibrositis, A double-blind comparison of maprotiline (Ludiomil) chlorimipramine, and placebo. Clin Trials Journal 1986;23:269-80.
9. Wolfe F, Smythe HA, Yunus MB. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia, Report of the muticenter criteria committee. Arthritis Rheum 1990;33:160-72.
10. Smythe HA, Moldovsky H. Two contributions to understanding of the fibrositis syndrome. Bull Rheum Dis 1977:28:928-31.
11. Yunus M, Masi AT, Calabro JJ. Primary fibromyalgia (fibrositis), Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
12. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-99.
13. Boureau F, Luu M, Doubrere JF. Comparative study of the validity of four French McGill Pain Questionnaire (MPQ) versions. Pain 1992; 50:59-65.
14. Simms RW, Felson DT, Goldenberg DL. Development of preliminary criteria for response to treatment in fibromylagia syndrome. J Rheumatol 1991;18:1558-63.
15. Hewett JE, Buckelew SP, Johnson JC, Shaw SE, Huyser B, Fu YZ. Selection of measures suitable for evaluating change in fibromyalgia clinical trials. J Rheumatol 1995;22:2307-12.
16. Burckhardt CS, Clark SR, Benett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1994;21: 714-20.
17. Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J, The "French Group for quality of Life Research". Quality of Life in Women with Fibromyalgia Syndrome: Validation of the QIF, The French Version of the Fibromyalgia Impact Questionnaire (FIQ). J Rheumatol in press, 2003.
18. Carette S, Bell M, Reynolds, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia, A randomized, double-blind clinical trial. Arthritis Rheum 1994;37: 32-40.
19. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997; 40:1560-70.
20. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995;24: 360-5.
21. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharm Res 1998;1:13-9.
22. Russel IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000;6:250-7.
23. Russel IJ, Fletcher EM, Michalek JE. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam, A double-blind, placebo-controlled study. Arthritis Rheum 1991;34: 552-60.
24. Carrera JQ, Castano AV, Gomez JP, Rodriguez AF, Medano WH, Rubeio AG, et al. Comparison of tenoxicam and bromazepam in the treatment of fibromyalgia: a randomized, double-blind, placebo controlled trial. Pain 1996;65:221-5.
25. Bennett MI, Tai YM. Intravenous lignocaine in the management of primary fibromyalgia syndrome. Int J Clin Pharm Res 1995;15:115-9.
26. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;4:341-51.
27. Carette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. A double-blind placebo-controlled study. Arthritis Rheum 1986;29:655-9.
28. Goldenberg DL, Felson DT, Dinerman H. A randomized controlled trial of amitriptyline and naproxen in the treatment of fibromyalgia syndrome. Arthritis Rheum 1986;29:1371-7.
29. Scudds RA, McCain GA, Rollmman GB, Harth M. Improvement in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989;16:98-103.
30. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo-controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994;23:255-9.
31. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmic C. A Randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39: 1852-9.
32. Norregaard J, Volkmann H, Danneskiol-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 1995;61:445-9.
33. Andenberg UM, Marteinsdottir I, Von Knorring L. Citalopram in patients with fibromyalgia - a randomized, double-blind, placebo-controlled study. Eur J Pain 2000;4:27-35.
34. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptylin in the treatment of fibromyalgia females without psychiatric disorders. Br J Rheumatol 1998;37:1279-86.
35. Olin R, Klein R, Berg PA. A randomised double-blind 16 week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids. Clin Rheumatol 1998;17:89-94.
36. Farber L, Stratz T, Buckle W, Spath M, Pongratz D, Lautenschlager J, et al. Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheumatol 2000;113:49-54.
37. Papadopoulos IA, Georgiou PE, Katsimbri PP, Drosos AA. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study. Clin Rheumatol 2000;19:6-8.
38. Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-Alexander M, Martin MY, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health-care seeking behavior rather than to illness. Arthritis Rheum 1996;39:436-45.
39. Moldofsky H, Franklin AL, Mously C, Roth-Schechter B, Reynolds WJ. The effect of Zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo-controlled modified crossover study. J Rheumatol 1996;23:529-33.
40. Drewes AM, Andreasen A, Jennum P, Nielsen KD. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-93.
41. Gronblad M, Nykanen J, Konttinen Y, Jarvinen E, Helve T. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients, A double-blind randomized trial. Clin Rheumatol 1993;12:186-91.
42. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis, A double-blind controlled study. Arthritis Rheum 1988;31:1535-12.
43. Reynolds WJ, Moldofsky H, Saskin P, Lue FA. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991;18:452-4
44. Vaeroy H, Abrahamsen A, Forre O, Kass E. Treatment of fibromyalgia (fibrositis syndrome): a parrallel double-blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo. Clin Rheumatol 1989;8:245-50.
45. Russell IJ, Michalek JE, Flechas JD, Abraham GE. Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo, controlled, crossover pilot study. J Rheumatol 1995; 22:953-8.
46. Bennett RM, Clark SR, Burckhardt CS, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone therapy in the treatment of fibromyalgia. Am J Med 1998;104:227-31.
47. Caruso I, Saerzi Puttini PC, Bocassini L, Santandrea S, Locati M, Volpato R, et al. A double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1987;15:154-9.
48. Bessette L, Carette S, Fossel AH, Lew RA. Scand J Rheumatol 1998;27:112-6.
49. Jacobsen S, Danneskiold-Samsoe B, Bach-Andersen R. Oral S-adenosylmethionine in primary fibromyalgia, Double-blind clinical evaluation. Scand J Rheumatol 1991;20:294-302.
50. Tavoni A, Vitali C, Bombardieri L. Evaluation of S-adenosylmethionine in primary fibromyalgia: A double blind cross-over study. Am J Med 1987;83(Suppl. 5A):107-10.
51. Tavoni A, Jeracitano G, Cirigliano G. Evaluation of S-adenosylmethionine in secondary fibromyalgia: a double-blind study. Clin Exp Rheumatol 1990;16:106-7.
52. Emberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. Short-term effect of glucocorticoid injection into the superficial masseter muscle of patients with chronic myalgia: a comparison between fibromyalgia and localized myalgia. J Orofac Pain 1997;11:249-57.
53. Pioro-Boisset M, Esdaile JM, Ftzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 1996;9:13-7.
54. Arnold LM, Keck PE, Wedge JA. Antidepressant in fibromyalgia, A meta-analysis and review. Psychosomatics 2000;41:104-13.
55. Bennett RM. Multidisciplinary group programs to treat fibromyalgia patients. Rheum Dis Clin N Am 1996;22:351-67.
56. White KP, Harth M. An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS). Pain 1996;64:211-9.
57. Bennett RM. The rational management of fibromyalgia patients. Rheum Dis Clin N Am 2002;28:181-99.